GRI has been appointed as the sole UK distributor for Marine BioProducts International (MPB), and will promote MBP's ranges of premium agar and agarose
This new partnership further enhances GRI's product portfolio but also presents significant advantages and benefits to UK laboratories, where agar and agarose products are essential for both routine analysis and cutting edge research.
Marine BioProducts International (MBP) is positioned to become a prime supplier to global life sciences and biotechnology industries. MBP's ranges of products are critical to numerous companies and research organisations working in this sector.
Through significant research and development processes, MBP now offer products with sustainable levels of purity and reliability, which will prove vital for many researchers and businesses in the life sciences arena.
Marine BioProducts is the first company in the world to grow one of biotech's most essential raw materials. The ability to cultivate a consistent and high quality supply of seaweed used to produce agar and agarose for microbiological uses is key to the product and company's success.
Unique processes are performed at MBP's production facility to produce speciality premium agar and agarose products for diverse end uses.
These products meet and exceed industry standards and are delivered consistently at a competitive cost.
Having achieved its research and development milestones, Marine BioProducts has obtained all of the necessary certification for it's initial products.
With firm scientific foundations at its core, MBP has now scaled up production to meet international demands for their technology and products.
GRI will initially promote the four main product lines from MBP, namely, Microbiological Agar, Noble Agar, Plant Propagation Agar, and DNA Agar.
This range will increase as MBP researches and develops additional products.
